Susquehanna International Group, LLP Vincerx Pharma, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 21,371 shares of VINC stock, worth $13,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,371
Previous 31,980
33.17%
Holding current value
$13,891
Previous $23,000
78.26%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VINC
# of Institutions
21Shares Held
4.8MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.11 Million0.1% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$579,6170.01% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$410,4080.0% of portfolio
-
Armistice Capital, LLC New York, NY567KShares$368,5570.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA286KShares$186,1410.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $13.8M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...